DA
DAVEW
Dave Inc./DE
$0.6137
0.00%
$14.2M
No data for this timeframe.
Vol
Market Cap$14.2M
Cap SizeNano Cap
Inst. Holders6 funds
Inst. Value$1.4M
Inst. Activity1 buys / 0 sells
SEC Reports1
Recent Activity
Apr 20, 2026
SEC
Analysis based on filing metadata only — document content was unavailable
DEFA14A — Impact 3/10
Inst.
TORONTO DOMINION BANK — ADD
349,135 shares ($342.2K)
Inst.
TORONTO DOMINION BANK — TRIM
254,800 shares ($276.5K)
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| LMR Partners LLP | $1.2M | — |
| TORONTO DOMINION BANK | $117.3K | ADD |
| WOLVERINE ASSET MANAGEMENT LLC | $58.1K | — |
| D. E. Shaw & | $13.3K | — |
| GOLDMAN SACHS GROUP INC | $3.5K | — |
6 institutional holders with $1.4M total value (4,578,078 shares) as of 2026-Q1. Top holders: LMR, TORONTO, WOLVERINE.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | LMR Partners LLP | 3,932,432 | $1.2M | 86.0% | — |
| 2 | TORONTO DOMINION BANK | 390,891 | $117.3K | 8.6% | ADD +37.0% |
| 3 | WOLVERINE ASSET MANAGEMENT LLC | 193,748 | $58.1K | 4.2% | — |
| 4 | D. E. Shaw & Co., Inc. | 49,200 | $13.3K | 1.0% | — |
| 5 | GOLDMAN SACHS GROUP INC | 11,707 | $3.5K | 0.3% | — |
| 6 | Clear Street Group Inc. | 100 | $30.00 | 0.0% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| TORONTO DOMINION BANK | ADD | 254,800 | 349,135 | +37.0% | $342.2K | 2025-Q4 |
| TORONTO DOMINION BANK | TRIM | 452,469 | 254,800 | -43.7% | $276.5K | 2025-Q3 |
| UBS Group AG | TRIM | 2,671 | 1,228 | -54.0% | $230.00 | 2025-Q1 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
1 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 1 neutral. Avg impact: 3.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.2B | 29.8% | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.2B | 23.5% | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.7B | 29.0% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.9B | 19.5% | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.